2019 Q1 Form 10-K Financial Statement

#000156459019007562 Filed on March 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018
Revenue $5.000K $7.000K $47.00K
YoY Change 0.0% -41.67% 4.44%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.040M $5.250M $42.72M
YoY Change -58.06% -60.79% -25.21%
% of Gross Profit
Research & Development $11.70M $11.88M $55.72M
YoY Change -11.96% 4.03% 32.52%
% of Gross Profit
Depreciation & Amortization $2.395M $2.790M $9.555M
YoY Change 47.57% 77.71% 71.67%
% of Gross Profit
Operating Expenses $18.34M $17.73M $98.44M
YoY Change -35.17% -30.23% -0.74%
Operating Profit -$18.34M -$17.72M -$98.39M
YoY Change -35.18% -30.22% -0.74%
Interest Expense $410.0K $350.0K $1.890M
YoY Change 1142.42% -55.7% -48.08%
% of Operating Profit
Other Income/Expense, Net $47.00K -$100.0K $1.660M
YoY Change -92.67% 66.67% -24.68%
Pretax Income -$17.92M -$17.47M -$96.73M
YoY Change -35.17% -29.16% -0.19%
Income Tax -$36.00K -$130.0K -$503.0K
% Of Pretax Income
Net Earnings -$17.89M -$17.34M -$96.23M
YoY Change -35.01% -29.19% -0.2%
Net Earnings / Revenue -357700.0% -247714.29% -204736.17%
Basic Earnings Per Share
Diluted Earnings Per Share -$220.2K -$219.0K -$1.216M
COMMON SHARES
Basic Shares Outstanding 79.09M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.55M $74.15M $74.90M
YoY Change -19.09% -42.14% -41.58%
Cash & Equivalents $22.28M $16.82M $16.80M
Short-Term Investments $76.27M $57.33M $58.10M
Other Short-Term Assets $80.00K $42.00K $2.500M
YoY Change -75.61% -84.73% -19.35%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $113.4M $88.77M $88.80M
YoY Change -10.54% -32.98% -32.98%
LONG-TERM ASSETS
Property, Plant & Equipment $67.92M $76.89M $76.90M
YoY Change -11.56% 0.21% 0.26%
Goodwill
YoY Change
Intangibles $0.00 $565.0K
YoY Change -80.01%
Long-Term Investments $13.40M $14.20M $14.20M
YoY Change 57.65% 67.06% -62.73%
Other Assets $314.0K $1.527M $1.500M
YoY Change -21.5% 362.73% 400.0%
Total Long-Term Assets $94.83M $93.18M $93.20M
YoY Change -7.93% -21.02% -20.95%
TOTAL ASSETS
Total Short-Term Assets $113.4M $88.77M $88.80M
Total Long-Term Assets $94.83M $93.18M $93.20M
Total Assets $208.3M $182.0M $182.0M
YoY Change -9.37% -27.35% -27.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.804M $2.793M $2.800M
YoY Change -22.11% -52.38% -52.54%
Accrued Expenses $20.24M $21.10M $21.10M
YoY Change 67.29% 87.31% 86.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $1.000M $1.000M
YoY Change -66.67% 233.33% 233.33%
Total Short-Term Liabilities $27.70M $27.26M $27.30M
YoY Change 42.79% 30.63% 30.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $5.900M $5.900M
YoY Change -100.0% 247.06% 247.06%
Other Long-Term Liabilities $12.80M $0.00 $2.700M
YoY Change 58.02% -100.0% -68.24%
Total Long-Term Liabilities $12.80M $0.00 $8.600M
YoY Change 30.61% -100.0% -15.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.70M $27.26M $27.30M
Total Long-Term Liabilities $12.80M $0.00 $8.600M
Total Liabilities $40.50M $35.94M $35.90M
YoY Change 37.29% 13.76% 13.61%
SHAREHOLDERS EQUITY
Retained Earnings -$595.0M
YoY Change 19.3%
Common Stock $741.3M
YoY Change 3.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $167.8M $146.0M $146.0M
YoY Change
Total Liabilities & Shareholders Equity $208.3M $182.0M $182.0M
YoY Change -9.36% -27.35% -27.32%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018
OPERATING ACTIVITIES
Net Income -$17.89M -$17.34M -$96.23M
YoY Change -35.01% -29.19% -0.2%
Depreciation, Depletion And Amortization $2.395M $2.790M $9.555M
YoY Change 47.57% 77.71% 71.67%
Cash From Operating Activities -$13.08M -$14.03M -$63.38M
YoY Change -15.69% 2.86% 29.93%
INVESTING ACTIVITIES
Capital Expenditures $2.104M -$2.040M $13.10M
YoY Change -57.08% -82.17% -62.37%
Acquisitions
YoY Change
Other Investing Activities -$17.36M $17.96M $70.20M
YoY Change -321.99% -42.38% -47.76%
Cash From Investing Activities -$19.46M $15.91M $57.10M
YoY Change -766.4% -19.36% -42.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $228.0K
YoY Change -98.5%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 39.20M -370.0K -771.0K
YoY Change -46211.76% -88.22% -97.8%
NET CHANGE
Cash From Operating Activities -13.08M -14.03M -63.38M
Cash From Investing Activities -19.46M 15.91M 57.10M
Cash From Financing Activities 39.20M -370.0K -771.0K
Net Change In Cash 6.658M 1.510M -7.051M
YoY Change -152.52% -48.81% -144.66%
FREE CASH FLOW
Cash From Operating Activities -$13.08M -$14.03M -$63.38M
Capital Expenditures $2.104M -$2.040M $13.10M
Free Cash Flow -$15.18M -$11.99M -$76.48M
YoY Change -25.63% 445.0% -8.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16821000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23872000
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
90000
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
154000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13810000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4152000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
57328000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
104280000
CY2018Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
723000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
741246000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-594981000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181950000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-267000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
146006000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79087734
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79087734
CY2018 us-gaap Revenues
Revenues
47000
CY2017 us-gaap Revenues
Revenues
45000
CY2016 us-gaap Revenues
Revenues
44000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55718000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57121000
CY2018Q4 us-gaap Liabilities
Liabilities
35944000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42044000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29153000
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79087734
CY2018Q2 dei Entity Public Float
EntityPublicFloat
86100000
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018Q4 us-gaap Assets
Assets
181950000
CY2018Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8500000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
565000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1527000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2793000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21104000
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1696000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1667000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27260000
CY2018Q4 nk Financing Obligation Noncurrent
FinancingObligationNoncurrent
5945000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2739000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
95391000
CY2016 us-gaap Operating Expenses
OperatingExpenses
124544000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36997000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250440000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-498713000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
218844000
CY2017Q4 us-gaap Liabilities
Liabilities
31596000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
717930000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-381000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79021878
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79021878
CY2018 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
57000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42718000
CY2018 us-gaap Operating Expenses
OperatingExpenses
98436000
CY2017 us-gaap Investment Income Net
InvestmentIncomeNet
2665000
CY2017 us-gaap Operating Expenses
OperatingExpenses
99165000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-98389000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-99120000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-124500000
CY2016 us-gaap Investment Income Net
InvestmentIncomeNet
3097000
CY2017 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
618000
CY2016 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
66000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-493000
CY2018 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
433000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-120809000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.47
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-96423000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80583910
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-65000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-97000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-96520000
CY2017Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
0
CY2018Q4 us-gaap Assets Current
AssetsCurrent
88772000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
132458000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
5701000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
29600000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76885000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76726000
CY2017Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8500000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2826000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
330000
CY2017Q4 us-gaap Assets
Assets
250440000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5865000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11267000
CY2017Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2363000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1373000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20868000
CY2018Q4 nk Build To Suit Lease Liability Noncurrent
BuildToSuitLeaseLiabilityNoncurrent
0
CY2017Q4 nk Build To Suit Lease Liability Noncurrent
BuildToSuitLeaseLiabilityNoncurrent
4909000
CY2017Q4 nk Financing Obligation Noncurrent
FinancingObligationNoncurrent
1741000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3325000
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
0
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
498000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
255000
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81979005
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
5000
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
32000
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
97000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-92000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-120901000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
355995000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1373000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73852000
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0
CY2016 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1106000
CY2016 nk Change In Accounting Principle Forfeiture Adjustment
ChangeInAccountingPrincipleForfeitureAdjustment
0
CY2016 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
15847000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
293418000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1154000
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1039000
CY2017 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
61000
CY2017 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
15227000
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-97000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23382000
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
123000
CY2018 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
228000
CY2018 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
186000
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
114000
CY2018 us-gaap Profit Loss
ProfitLoss
-96226000
CY2017 us-gaap Profit Loss
ProfitLoss
-96423000
CY2016 us-gaap Profit Loss
ProfitLoss
-120809000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
23382000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
36997000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
73852000
CY2016 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
52000
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-92000
CY2017Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
340000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9555000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5566000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3607000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1100000
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2182000
CY2018 nk Non Cash Interest Income Expense From Operating Activities
NonCashInterestIncomeExpenseFromOperatingActivities
-291000
CY2017 nk Non Cash Interest Income Expense From Operating Activities
NonCashInterestIncomeExpenseFromOperatingActivities
-720000
CY2016 nk Non Cash Interest Income Expense From Operating Activities
NonCashInterestIncomeExpenseFromOperatingActivities
573000
CY2018 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-209000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-463000
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1597000
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-64000
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-18000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-498000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-497000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-575000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-113672000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
477000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
19932000
CY2018 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
3000
CY2017 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
32000
CY2016 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
137000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9818000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-156000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1458000
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1151000
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-458000
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-153000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
150000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
888000
CY2018 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
12708000
CY2017 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-299000
CY2016 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2127000
CY2018 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-685000
CY2017 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1562000
CY2016 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
378000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-508000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1201000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1754000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63381000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48780000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38593000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13102000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34815000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6560000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
412000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2018 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
723000
CY2017 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2016 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8500000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
94770000
CY2017 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
111355000
CY2016 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
272999000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
165284000
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
254222000
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
165887000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
57101000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
99552000
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1106000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-771000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34983000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15560000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7051000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
15789000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-167825000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24051000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8262000
CY2016 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
32000
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
228000
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15227000
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15847000
CY2018 nk Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
57000
CY2017 nk Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
1215000
CY2016 nk Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
1425000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
123000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1039000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
176087000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17000000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8083000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
179000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
179000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
179000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
475000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
668000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
66000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
CY2018 nk Noncash Property And Equipment Purchases Acquired Under Capital Lease
NoncashPropertyAndEquipmentPurchasesAcquiredUnderCapitalLease
0
CY2017 nk Noncash Property And Equipment Purchases Acquired Under Capital Lease
NoncashPropertyAndEquipmentPurchasesAcquiredUnderCapitalLease
19448000
CY2016 nk Noncash Property And Equipment Purchases Acquired Under Capital Lease
NoncashPropertyAndEquipmentPurchasesAcquiredUnderCapitalLease
0
CY2018 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
4664000
CY2017 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
9500000
CY2016 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
2753000
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
123000
CY2017 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-97000
CY2016 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-102000
CY2018 nk Cashless Exercise Of Stock Options And Warrants
CashlessExerciseOfStockOptionsAndWarrants
94000
CY2017 nk Cashless Exercise Of Stock Options And Warrants
CashlessExerciseOfStockOptionsAndWarrants
16000
CY2016 nk Cashless Exercise Of Stock Options And Warrants
CashlessExerciseOfStockOptionsAndWarrants
456000
CY2018 nk Estimated Fair Market Value Of Building Under Build To Suit Lease
EstimatedFairMarketValueOfBuildingUnderBuildToSuitLease
0
CY2017 nk Estimated Fair Market Value Of Building Under Build To Suit Lease
EstimatedFairMarketValueOfBuildingUnderBuildToSuitLease
0
CY2016 nk Estimated Fair Market Value Of Building Under Build To Suit Lease
EstimatedFairMarketValueOfBuildingUnderBuildToSuitLease
5139000
CY2018 nk Noncash Lease Incentive With Related Party
NoncashLeaseIncentiveWithRelatedParty
0
CY2017 nk Noncash Lease Incentive With Related Party
NoncashLeaseIncentiveWithRelatedParty
0
CY2016 nk Noncash Lease Incentive With Related Party
NoncashLeaseIncentiveWithRelatedParty
849000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to the valuation of warrants, stock-based compensation, the valuation allowance for deferred tax assets, preclinical and clinical trial accruals, impairment assessments, useful lives of long-lived assets, and the valuation of build-to-suit lease assets. The Company bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash and cash equivalents and marketable debt securities.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s cash and cash equivalents are with one major financial institution in the U.S. and one in Korea.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Drug candidates developed by the Company will require approvals or clearances from the U.S.&#160;Food and Drug Administration&#160;(FDA) or international regulatory agencies prior to commercial sales. There can be no assurance that the Company&#8217;s drug candidates will receive any of the required approvals or clearances. If the Company was to be denied approval or clearance or any such approval or clearance was to be delayed, it would have a material adverse impact on the Company.</p>
CY2018 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2017 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2016 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2018 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P4Y
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 nk Cash And Cash Equivalents Original Maturities
CashAndCashEquivalentsOriginalMaturities
P3M
CY2018 nk Maximum Original Maturity Period Of Short Term Marketable Securities
MaximumOriginalMaturityPeriodOfShortTermMarketableSecurities
P12M
CY2018 nk Minimum Original Maturity Period Of Long Term Marketable Securities
MinimumOriginalMaturityPeriodOfLongTermMarketableSecurities
P12M
CY2018Q4 nk Number Of Products Approved For Commercial Sale
NumberOfProductsApprovedForCommercialSale
0
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24950411
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018Q4 nk Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories
FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
0
CY2017Q4 nk Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories
FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
0
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000
CY2018 nk Variable Consideration Related To Milestone Payment
VariableConsiderationRelatedToMilestonePayment
0
CY2018 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
0
CY2017Q4 us-gaap Prepaid Rent
PrepaidRent
373000
CY2016Q4 nk Fair Value Inputs Transfers Into Or Out Of Level One Level Two Or Level Three Categories
FairValueInputsTransfersIntoOrOutOfLevelOneLevelTwoOrLevelThreeCategories
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q4 nk Prepaid License Fees
PrepaidLicenseFees
597000
CY2018Q4 nk Equipment Deposits Current
EquipmentDepositsCurrent
0
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q4 nk Equipment Deposits Current
EquipmentDepositsCurrent
482000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
42000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
275000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24302527
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24890156
CY2018Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
10882000
CY2018Q4 us-gaap Prepaid Rent
PrepaidRent
536000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88446000
CY2017Q4 us-gaap Supplies
Supplies
210000
CY2018Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
473000
CY2017Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
764000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
343000
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
572000
CY2018Q4 nk Insurance Premium Financing Asset
InsurancePremiumFinancingAsset
339000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
81029000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11561000
CY2017Q4 nk Insurance Premium Financing Asset
InsurancePremiumFinancingAsset
0
CY2018Q4 nk Prepaid Equipment Maintenance
PrepaidEquipmentMaintenance
329000
CY2018Q4 us-gaap Supplies
Supplies
532000
CY2017Q4 nk Prepaid Equipment Maintenance
PrepaidEquipmentMaintenance
123000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4303000
CY2018 us-gaap Depreciation
Depreciation
7300000
CY2017 us-gaap Depreciation
Depreciation
3300000
CY2016 us-gaap Depreciation
Depreciation
1000000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2300000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2300000
CY2018Q4 nk Prepaid Services
PrepaidServices
230000
CY2017Q4 nk Prepaid Services
PrepaidServices
416000
CY2018Q4 nk Prepaid License Fees
PrepaidLicenseFees
104000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2600000
CY2018Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
1205000
CY2017Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
0
CY2018Q4 us-gaap Security Deposit
SecurityDeposit
113000
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
127000
CY2018Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
30000
CY2017Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
24000
CY2018Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
12000000
CY2017Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0
CY2018Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
3341000
CY2017Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
6212000
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2079000
CY2017Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1930000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
943000
CY2017Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
944000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
912000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1048000
CY2018Q4 nk Accrued Preclinical And Clinical Trial Costs
AccruedPreclinicalAndClinicalTrialCosts
704000
CY2017Q4 nk Accrued Preclinical And Clinical Trial Costs
AccruedPreclinicalAndClinicalTrialCosts
521000
CY2018Q4 nk Accrued Laboratory Equipment And Supplies
AccruedLaboratoryEquipmentAndSupplies
678000
CY2017Q4 nk Accrued Laboratory Equipment And Supplies
AccruedLaboratoryEquipmentAndSupplies
305000
CY2018Q4 nk Accrued Franchise Sales Use And Property Taxes
AccruedFranchiseSalesUseAndPropertyTaxes
250000
CY2017Q4 nk Accrued Franchise Sales Use And Property Taxes
AccruedFranchiseSalesUseAndPropertyTaxes
198000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
197000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
109000
CY2018Q4 nk Financing Obligation Current
FinancingObligationCurrent
965000
CY2017Q4 nk Financing Obligation Current
FinancingObligationCurrent
284000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
598000
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
520000
CY2018Q4 nk Build To Suit Lease Liability Current
BuildToSuitLeaseLiabilityCurrent
0
CY2017Q4 nk Build To Suit Lease Liability Current
BuildToSuitLeaseLiabilityCurrent
334000
CY2018Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
104000
CY2017Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
235000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
2317000
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
4225000
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
5168000
CY2018 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-463000
CY2017 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-1597000
CY2016 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-2182000
CY2018 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
3000
CY2017 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
37000
CY2016 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
111000
CY2018 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
137378000
CY2017 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2016 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2017Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8500000
CY2018Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
32010000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
26000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
386000
CY2018 nk Equity Securities Description
EquitySecuritiesDescription
As the preferred stock is not considered in-substance common stock, the investment is not within the scope of accounting for the investment under the equity method. As the preferred stock does not have a readily determinable fair value and does not qualify for the practical expedient to estimate fair value in accordance with ASC 820, Fair Value Measurement, the Company has elected to apply the measurement alternative under ASC 321, Investments—Equity Securities, pursuant to which the Company measures its investment at cost, less impairment, adjusted for observable price changes in an orderly market for an identical or similar investment of the same issuer.
CY2018 nk Available For Sale Securities Or Held To Maturity Period
AvailableForSaleSecuritiesOrHeldToMaturityPeriod
P4M24D
CY2018Q4 nk Available For Sale Securities And Held To Maturity Amortized Cost
AvailableForSaleSecuritiesAndHeldToMaturityAmortizedCost
64009000
CY2018Q4 nk Available For Sale Securities And Held To Maturity Gross Unrealized Gain
AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedGain
1000
CY2018Q4 nk Available For Sale Securities And Held To Maturity Gross Unrealized Losses
AvailableForSaleSecuritiesAndHeldToMaturityGrossUnrealizedLosses
-258000
CY2018Q4 us-gaap Available For Sale Securities And Held To Maturity Securities
AvailableForSaleSecuritiesAndHeldToMaturitySecurities
63752000
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
137759000
CY2018Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
29373000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
232000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
78808000
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
124000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
49519000
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
262000
CY2018 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
3000
CY2017 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
52000
CY2016 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
190000
CY2018 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2017 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
15000
CY2016 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
79000
CY2018 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
3000
CY2017 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
37000
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
111000
CY2018 nk Litigation Settlement Amount Paid By Insurance
LitigationSettlementAmountPaidByInsurance
10800000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2800000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2700000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2700000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4108000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4056000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3435000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3538000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2056000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
17193000
CY2018Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
138349
CY2018Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
200000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
5929903
nk Stock Repurchased And Retired Excluding Commission During Period Value
StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
31200000
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
100000
CY2018 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
138349
CY2017 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3633610
CY2016 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2157944
CY2018 nk Stock Repurchased And Retired Excluding Commission During Period Value
StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
200000
CY2017 nk Stock Repurchased And Retired Excluding Commission During Period Value
StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
15200000
CY2016 nk Stock Repurchased And Retired Excluding Commission During Period Value
StockRepurchasedAndRetiredExcludingCommissionDuringPeriodValue
15800000
CY2018Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
18800000
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
24950411
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23382000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36997000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
73852000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-94423000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-94734000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-118743000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-8000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-498000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2306000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2182000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2638000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-497000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-575000
CY2018 nk Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
-506000
CY2017 nk Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
-497000
CY2016 nk Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
-575000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
79281000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
73336000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
61915000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
42784000
CY2018Q4 nk Deferred Tax Assets Leases And Other Accrued Liabilities
DeferredTaxAssetsLeasesAndOtherAccruedLiabilities
2909000
CY2017Q4 nk Deferred Tax Assets Leases And Other Accrued Liabilities
DeferredTaxAssetsLeasesAndOtherAccruedLiabilities
1868000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
845000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
845000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
795000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
682000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
308000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
0
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
146053000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
119515000
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1000
CY2017Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
499000
CY2018Q4 nk Deferred Tax Liabilities Deferred Depreciation And Amortization
DeferredTaxLiabilitiesDeferredDepreciationAndAmortization
1279000
CY2017Q4 nk Deferred Tax Liabilities Deferred Depreciation And Amortization
DeferredTaxLiabilitiesDeferredDepreciationAndAmortization
494000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1280000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
993000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
144773000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
118522000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
144773000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
119020000
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
498000
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2018 nk Effective Income Tax Reconciliation Change In Net Operating Loss Percentage
EffectiveIncomeTaxReconciliationChangeInNetOperatingLossPercentage
0.00
CY2017 nk Effective Income Tax Reconciliation Change In Net Operating Loss Percentage
EffectiveIncomeTaxReconciliationChangeInNetOperatingLossPercentage
0.00
CY2016 nk Effective Income Tax Reconciliation Change In Net Operating Loss Percentage
EffectiveIncomeTaxReconciliationChangeInNetOperatingLossPercentage
0.086
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.062
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.053
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.036
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
-0.003
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.048
CY2016 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
-0.005
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.015
CY2018 nk Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsAct
0.00
CY2017 nk Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsAct
-0.534
CY2016 nk Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsAct
0.00
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.006
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.013
CY2018 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
-0.001
CY2017 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
-0.003
CY2016 nk Effective Income Tax Rate Reconciliation Stock Based Compensation Contribution
EffectiveIncomeTaxRateReconciliationStockBasedCompensationContribution
-0.003
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.003
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.008
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.267
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.087
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.477
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
CY2018Q4 nk Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Minimum Amount For Elimination Of Several Business Deductions And Credits Including Deductions For Certain Executive Compensation
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateMinimumAmountForEliminationOfSeveralBusinessDeductionsAndCreditsIncludingDeductionsForCertainExecutiveCompensation
1000000
CY2017Q4 nk Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Reduction In Deferred Tax Assets
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateReductionInDeferredTaxAssets
51700000
CY2018 nk Research And Development Cumulative Change In Ownership Percentage
ResearchAndDevelopmentCumulativeChangeInOwnershipPercentage
0.50
CY2018 nk Period Of Cumulative Ownership Change
PeriodOfCumulativeOwnershipChange
P3Y
CY2018Q4 nk Derecognized Deferred Tax Assets
DerecognizedDeferredTaxAssets
800000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
25800000
CY2018 us-gaap Income Tax Effects Allocated Directly To Equity Equity Transactions
IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions
200000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4634000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
812000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2755000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6577000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
798000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4608000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11983000
CY2018Q4 nk Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate
10900000
CY2018Q1 us-gaap Revenues
Revenues
5000
CY2018Q2 us-gaap Revenues
Revenues
4000
CY2018Q3 us-gaap Revenues
Revenues
31000
CY2018Q4 us-gaap Revenues
Revenues
7000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
28289000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
28282000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
24139000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
17726000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28284000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28278000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24108000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-17719000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-27519000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-27732000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-23635000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-17340000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79036614
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79107208
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79204765
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79177962
CY2017Q1 us-gaap Revenues
Revenues
11000
CY2017Q2 us-gaap Revenues
Revenues
14000
CY2017Q3 us-gaap Revenues
Revenues
8000
CY2017Q4 us-gaap Revenues
Revenues
12000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
25475000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
23834000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
24450000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
25406000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-25464000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-23820000
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79440591
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24442000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-25394000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-24515000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-23452000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-23969000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-24487000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
82138438
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81440816
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79358861

Files In Submission

Name View Source Status
0001564590-19-007562-index-headers.html Edgar Link pending
0001564590-19-007562-index.html Edgar Link pending
0001564590-19-007562.txt Edgar Link pending
0001564590-19-007562-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gjtiiown3pkf000001.jpg Edgar Link pending
gjtiiown3pkf000002.jpg Edgar Link pending
gjtiiown3pkf000003.jpg Edgar Link pending
gjtiiown3pkf000004.jpg Edgar Link pending
gjtiiown3pkf000005.jpg Edgar Link pending
gjtiiown3pkf000006.jpg Edgar Link pending
gjtiiown3pkf000007.jpg Edgar Link pending
gjtiiown3pkf000008.jpg Edgar Link pending
gjtiiown3pkf000009.jpg Edgar Link pending
gjtiiown3pkf000010.jpg Edgar Link pending
gjtiiown3pkf000011.jpg Edgar Link pending
gjtiiown3pkf000012.jpg Edgar Link pending
gjtiiown3pkf000013.jpg Edgar Link pending
gjtiiown3pkf000014.jpg Edgar Link pending
gjtiiown3pkf000015.jpg Edgar Link pending
gjtiiown3pkf000016.jpg Edgar Link pending
gjtiiown3pkf000017.jpg Edgar Link pending
gjtiiown3pkf000018.jpg Edgar Link pending
gjtiiown3pkf000019.jpg Edgar Link pending
gjtiiown3pkf000020.jpg Edgar Link pending
gjtiiown3pkf000021.jpg Edgar Link pending
gjtiiown3pkf000022.jpg Edgar Link pending
gjtiiown3pkf000023.jpg Edgar Link pending
gjtiiown3pkf000024.jpg Edgar Link pending
gjtiiown3pkf000025.jpg Edgar Link pending
gjtiiown3pkf000026.jpg Edgar Link pending
gjtiiown3pkf000027.jpg Edgar Link pending
nk-10k_20181231.htm Edgar Link pending
nk-20181231.xml Edgar Link completed
nk-20181231.xsd Edgar Link pending
nk-20181231_cal.xml Edgar Link unprocessable
nk-20181231_def.xml Edgar Link unprocessable
nk-20181231_lab.xml Edgar Link unprocessable
nk-20181231_pre.xml Edgar Link unprocessable
nk-ex211_7.htm Edgar Link pending
nk-ex231_11.htm Edgar Link pending
nk-ex311_6.htm Edgar Link pending
nk-ex312_10.htm Edgar Link pending
nk-ex321_9.htm Edgar Link pending
nk-ex322_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending